Article

AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.

Molecular Bacteriology and Immunology Group, Institute of Infection, Immunity & Inflammation, Centre for Biomolecular Sciences, University of Nottingham, University Park, Nottingham NG7 2RD, United Kingdom.
Vaccine (impact factor: 3.77). 07/2009; 27(38):5278-83. DOI:10.1016/j.vaccine.2009.06.047 pp.5278-83
Source: PubMed

ABSTRACT Actinobacillus pleuropneumoniae is a major respiratory pathogen of pigs; current vaccines provide only limited protection. AasP, a subtilisin-like serine protease, is a conserved outer membrane-localised autotransporter protein. We hypothesized that AasP would induce protective immunity and may thus constitute a useful component of a vaccine against A. pleuropneumoniae infection. Here we confirm experimentally that AasP is an antigenic in vivo-expressed protein. In pig protection studies, a detectable specific antibody response was induced in response to recombinant AasP. However, the vaccine was not capable of protecting pigs from colonization, infection or severe clinical disease resulting from challenge with the homologous A. pleuropneumoniae strain.

0 0
 · 
0 Bookmarks
 · 
57 Views

Keywords

A. pleuropneumoniae infection
 
Actinobacillus pleuropneumoniae
 
antigenic
 
colonization
 
conserved outer membrane-localised autotransporter protein
 
detectable specific antibody response
 
experimentally that AasP
 
homologous A. pleuropneumoniae strain
 
limited protection
 
major respiratory pathogen
 
pig protection studies
 
pigs
 
subtilisin-like serine protease